skip to the main content

Free Anti-Ustekinumab

Detecting the development of Anti-drug antibodies (ADAs) against Ustekinumab in patients being treated with Ustekinumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Ustekinumab can detect the presence of anti-drug antibodies against Ustekinumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

  • CE

Available Instruments

About Using Reagent

  • Sample Types

    Whole blood, Serum
  • Reaction Time

    12 mins
  • Detection Range

    2.5~100 ng/mL
  • Intended Use

    Quantitative determination of free antibodies to Ustekinumab in human whole blood/serum

In Your Medical Field

AFIAS Free Anti-Ustekinumab detects anti-drug antibodies against Ustekinumab in just 12 minutes using a small amount of blood. It provides valuable insights into patients’ response to the treatment of Ustekinumab.